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University of California, Davis, Sacramento, CaliforniaABSTRACT Apolipoprotein A-I plays a central role in the solution structure of high-density lipoproteins. Determining the
stoichiometry of lipid-bound apo A-I in the hydrated state is therefore fundamental to understanding how high-density lipopro-
teins form and function. Here, we use the quantum optical phenomenon of photon antibunching to determine the number of
apo A-I molecules bound to discoidal lipoproteins and compare this with values obtained by photon-counting histogram analysis.
Both the photon antibunching and photon-counting analyses show that reconstituted high-density lipoprotein particles contain
two apo A-I molecules, which is in agreement with the commonly accepted double-belt model.INTRODUCTIONApolipoprotein (apo) A-I is the major protein found in high-
density lipoproteins (HDL) and plays a central role in the
structure and metabolism of HDL particles. HDL (a.k.a.
good cholesterol) protects against atherosclerosis by car-
rying out reverse cholesterol transport, which delivers cho-
lesterol from tissues to the liver for excretion, and also
through its antiinflammatory properties (1,2). One can recon-
stitute HDL in vitro with high reproducibility using a sponta-
neous reaction of apo A-I with lipids. Reconstituted HDL
(rHDL), also commonly referred to as a lipid nanodisc, is
a discoidal complex that has been shown to exist in different
discrete sizes ranging from 7 to 15 nm. Because the lipid
structure of rHDL consists of a lamellar bilayer, it essentially
provides a platform that mimics a nanoscale, isolated patch
of cell membrane (supported by the apolipoproteins). Such
constructs have recently been used to reconstitute a variety
of membrane proteins in a soluble colloidal particle, in-
cluding cytochrome P450 and bacteriorhodopsin (3–5).
These properties provide improved sample dispersion, char-
acterization, and homogeneity, facilitating the biophysical
and biochemical examination of isolated, functional mem-
brane proteins (6,7). rHDL may also be a suitable alternative
to liposomes as targeted drug transport vehicles (8,9). Due to
the highly dynamic nature of the apolipoprotein-lipid inter-
action, many basic properties (e.g., their specific hydrated
shape in solution and the precise conformation of the apo-
lipoproteins surrounding the particles) are still uncertain.
However, on the basis of multiple lines of evidence, it is
widely assumed that a single rHDL particle contains two
molecules of apo A-I that circumscribe the perimeter of
a disk-shaped lipid bilayer in a belt-like conformation
(10–14). Here, we utilize a quantum optical property ofSubmitted June 6, 2011, and accepted for publication June 29, 2011.
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0006-3495/11/08/0970/6 $2.00single fluorescent molecules to test the hypothesis that
rHDL contains two apo A-I in the hydrated state, which is
difficult to determine with (and might be masked by) bulk
averaging analysis techniques.
Photon antibunching was first observed in the late 1970s
from resonance fluorescence of sodium atoms in atomic
beams (15). Shortly afterward, photon antibunching was re-
vealed by single fluorescent dyes trapped in a solid at low
temperature (16). Thanks to advances in laser technology
and detectors, it is now possible to observe antibunching
at room temperature from fluorescent dyes (17–19). Re-
cently, it was shown that this phenomenon can also be
used as an extremely powerful technique to count indepen-
dent emitters in biomolecules. Fore et al. (20) demonstrated
this by using antibunching to distinguish among singly,
doubly, and triply fluorescently labeled DNA oligonucleo-
tides, and Sy´kora et al. (21) applied this approach to study
protein conformation in ion channels. Here, we apply pho-
ton antibunching to determine the stoichiometry of lipid-
bound apo A-I and count the number of proteins per HDL
particle.MATERIALS AND METHODS
Methodology
Photon antibunching exploits the fact that a single fluorescent molecule can
only emit one photon at a time. In a simplified two-level energy diagram,
a molecule in an excited state requires a finite amount of time before it
relaxes back to the ground state, with the temporal separation between adja-
cent photons being determined mostly by the excited-state lifetime. This
effect is known as antibunching and represents the sub-Poissonian nature
of the emitted light. Only two or more molecules can emit photons simul-
taneously. Photon antibunching is usually performed in a Hanbury Brown-
Twiss interferometer setup that equally splits the photon flux with a 50/50
beam-splitter and sends them to two detectors attached to a coincidence
counter (22). The photons detected are then cross correlated between the
two channels in the picosecond/nanosecond regime, in which antibunchingdoi: 10.1016/j.bpj.2011.06.060
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known detectors with zero dead time. The primary objective of the Hanbury
Brown-Twiss setup is to measure the coincidence of photon counts at very
short time delays. Two photons detected by the two detectors, respectively,
within the fluorescence lifetime of the fluorescent molecules under study
are considered a coincident photon pair. By measuring the probability of de-
tecting photon pairs as a function of time delay t between the individual
photons, Ppair(t), we find that for emission from a single quantum system
at time zero, Ppair(0) ¼ 0 (e.g., a single molecule cannot emit two photons
at the same time). However, at time delays greater than zero, there is a finite
probability of detecting photon pairs because the same molecule is sub-
jected to multiple excitation-emission cycles. Experimentally, this is equiv-
alent to the measurement of the normalized second-order autocorrelation
function:
Gð2ÞðtÞ ¼ hIðt0ÞIðt0 þ tÞihIðtÞi2 ; (1)
which is defined as the probability of detecting a photon at time t given that
one has already been detected at time t0. A plot of the autocorrelation func-
tion at short timescales (~ns) gives rise to a dip at time zero, reflecting the
fact that the probability for detecting a second photon within a very short
time after the first one has been detected is very low (Fig. 1 A).
Kitson et al. (23) provided a mathematical analysis of G(2)(t) for dye
molecules in solution using a semiclassical approach and taking into account
the excited-state lifetime, triplet-state effects, and diffusion dynamics.
However, because antibunching occurs at the nanosecond timescale, which
is much shorter than the effects of molecular diffusion and triplet state
shelving, this simplifies the autocorrelation function to:
Gð2ÞðtÞ ¼ 1 1
N
ejt=tj; (2)FIGURE 1 (A) Dip in the second-order autocorrelation function is from
photon antibunching. Using CW excitation, the probability of detecting
photon pairs lies on the curve. (B) Using a pulsed laser source, the proba-
bility of detecting photon pairs resides on the lateral peaks, with the peaks
separated by 50 ns, determined by the laser repetition rate set at 20 Mhz.where t ¼ 1/(kexc þ kem) is the excited-state lifetime, with kexc being the
effective excitation pump rate and kem the rate of spontaneous emission.
Measurement of the autocorrelation function allows us to obtain excited-
state lifetime information and determine the number of molecules that
are present in a given complex.
Traditionally, photon antibunching measurements were performed with
a continuous wave (CW) excitation source, but this method is not very effi-
cient because the molecules are randomly excited and there is no control
over when photon emission will occur. Because all detectors have a dead
time (APD ~50 ns; Perkin Elmer), photons that fall within this time window
are lost. This drawback is mitigated by switching to a pulsed laser source.
If a laser with pulse width much less than the excited-state lifetime (typi-
cally <100 ps) is used as excitation, the probability that a single molecule
will emit a photon and then immediately be reexcited by the same laser
pulse is very low. Thus, if we excite all molecules within the laser focus
at predefined points in time, we know exactly when to expect fluorescence
photons from these molecules.
In experiments using pulsed sources, the probability of detecting photon
pairs is no longer restricted to events on the curve shown in Fig. 1 A (CW
excitation); rather, it resides on the lateral peaks that represent subsequent
excitation cycles (Fig. 1B). Because all coincident photon events must occur
within a few nanoseconds of the laser excitation, this implies that the
separation between photon peaks must be equal to the laser repetition rate,
which is set at 20 Mhz. Using pulsed laser excitation, Tinnefeld et al. (19)
and Sy´kora et al. (21) demonstrated that photon antibunching can be used
to count the number of fluorescent molecules N, using the formula
Mc
Ml
¼ 1 1
N
(3)
and measuring the area of a central photon count peakMc, representing zero
coincidence time, with respect to the area of all other lateral peaks Ml in
a photon coincidence diagram. The ratio Mc=Ml is a measure of the prob-
ability of detecting photon pairs per laser pulse. For a single molecule,
the central peak will have an area of zero (i.e., no peak), whereas a dimer
will give rise to a peak of half the amplitude of the lateral peaks, a trimer
will have two-thirds the amplitude of the lateral peaks, and so on.Materials
We synthesize rHDL using a spontaneous reconstitution of apo A-I and
lipid vesicles that are mixed in a 100:1 DMPC/apoA-I molar ratio as
described previously (24). Before reconstitution is performed, site-specific
mutagenesis is used to express a clone of apo A-I containing a single
cysteine at position 55. Of importance, we have shown that this Ser55->Cys
substitution does not affect the folding or lipid-binding properties of the
modified apoA-I relative to the native protein (25). This apo A-I clone is
then reacted with Alexa647-maleimide derivatives via sulfhydryl-male-
imide chemistry and subsequent purification in a separation column to
result in fluorescently labeled apo A-I, each molecule of which carries
just a single fluorophore. For accurate stoichiometry measurements, we
further purify the rHDL complex using HPLC to eliminate unbound
proteins and lipids, and to select a fraction that corresponds to 150 kDa,
which represents the typical molecular mass of rHDL.Instrumentation
We conduct our experiments with a MicroTime 200 confocal fluorescence
spectroscopy system (PicoQuant GmbH, Berlin, Germany) equipped with
a pulsed diode laser (640 nm wavelength, 80 ps pulse width, 20 Mhz repe-
tition rate). The laser is focused through an Olympus 1.45 NA 100 oil
objective to a diffraction-limited spot of ~250 nm diameter at a height of
5 mm above a glass coverslip surface. The laser power is 30 mw at the
sample. The emission is split by a 50/50 beam-splitter and directed toBiophysical Journal 101(4) 970–975
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tham, MA). Photoelectron pulses from the detectors are used as start-stop
signals for time-correlated single-photon counting (TCSPC) electronics
(Picoharp 300, PicoQuant GmbH, Berlin, Germany). The PicoHarp 300
records the photon arrival time from the last excitation pulse (microtime)
with 50 ps time resolution, and the arrival time from the start of the exper-
iment (macrotime) with 50 ns time resolution.RESULTS AND DISCUSSION
To ensure the acquisition of single-molecule statistics, the
concentration of lipid-bound apo A-I is diluted to a final
concentration below 1 nM. This low concentration ensures
a high probability that only one particle will be present in
the detection volume at any given point in time. To verify
this, we measured freely diffusing particles in phosphate-
buffered saline using fluorescence correlation spectroscopy
(FCS). The amplitude of the autocorrelation curve G(0) is
inversely proportional to the average number of particles,
n, in the laser excitation volume. Using G(0) z 13, we
calculated a value nz 1/G(0)z 0.08 (Fig. 2 A), indicatingFIGURE 2 Photon antibunching histograms of lipid-bound apoA-I at low
concentration (<1 nM). The central peak is highlighted by a box. (A) FCS
autocorrelation with G(0)z 13, which gives N¼ 1/G(0)z 0.08, indicating
a low probability of detecting more than one particle in the laser excitation
volume. (B) The singly labeled (control) sample shows a very small central
peak due to single-molecule emission. (C) The doubly labeled sample
(of interest) has a central peak with approximately half the area of the
lateral peaks, which is indicative of two protein molecules being present
in the sample at any time.
Biophysical Journal 101(4) 970–975that on average there was only one particle present within
the detection volume. Using FCS, we measured an average
diffusion time of 6005 25 ms over multiple measurements,
corresponding to a diffusion coefficient of 26 5 1 mm2/s.
The hydrodynamic radius of the rHDL is calculated to be
9.3 5 0.4 nm via the Stokes-Einstein equation, D ¼ KT/
(6pnRH), but one should keep in mind that the shape of
these particles is likely not spherical, as is assumed for
this model.
For the photon antibunching analysis, we performed
a total of eight measurements (10 min each) for lipid-bound
apoA-I in phosphate-buffered saline diffusing through
the laser excitation volume. We obtained a control sample
using a 10:1 (unlabeled/labeled) apo A-I ratio. The apo
A-I was then reconstituted with lipid vesicles to form discs
that contained mostly unlabeled lipid-bound apo A-I.
A small fraction contained one label. This control sample
is referred to as singly labeled. In principle, the singly
labeled control sample is equivalent to a single quantum
emitter and should register no antibunching peak at time
zero. However, even with a 10:1 unlabeled/labeled ratio,
there is a finite chance of having two labeled apoA-I
proteins on the same disc. If the chance of a protein being
labeled is p ¼ 1/11, the fraction of discs with two labeled
proteins is p/{2(1  p)} ¼ 0.05.
The fraction of the singly labeled sample that contains
two labeled proteins leads to a finite, nonzero antibunching
peak at time zero. If there are two species in the solution
with concentrations n1 and n2, molecular brightness values
of ε1 and ε2, and one-molecule correlation functions f1(t)
and f2(t), the total correlation function is given by (21):
CðtÞ ¼ 1þ n1ε
2
1 f1ðtÞ þ n2ε22 f2ðtÞ
ðn1ε1 þ n2ε2Þ2
: (4)
For our case, with n2 ¼ 0.05n1, and ε2 ¼ 2ε1, the contribu-
tion of f2(t) will be 20% of the correlation amplitude. The
peak at time zero has 50% of the amplitude of the other
peaks for f2(t), and 0% for f1(t). For the mixture, the peak
at time zero is predicted to have 10% of the amplitude of
the other peaks. This corresponds to a predicted value of
N ¼ 1.1 for the measurement. Hence, for the singly labeled
sample, we expect a value of 1.1.
In our experiment, the central peak is initially offset by
100 ns, which is a result of an electrical cable delay between
the two channel inputs of the PicoHarp. This offset was
compensated for in the histograms in Fig. 2, where the
central peak is now located at time zero.
For the singly labeled control sample, we determined
a value of Mc=Mlz0:15, which gives N ¼ 1.19 5 0.10
(Fig. 2 B). This value deviates from a true single-molecule
value of one due to background contributions from scat-
tering and the finite probability of detecting more than one
HDL particle in the excitation volume. In contrast, for the
actual sample of interest, which we will call doubly labeled,
FIGURE 3 Photon antibunching histograms of lipid-bound apoA-I at
high concentration from singly labeled (A) and doubly labeled (B) samples.
The central peak is highlighted by a box.
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2.10 5 0.19 for rHDL. This is in excellent agreement
with the value of two apoA-I, assuming that two proteins
are bound to the lipids in the commonly accepted double-
belt conformation (Fig. 2 C). These values are summarized
in Table 1.
Photon antibunching spectroscopy is usually performed
with very-low-concentration samples, such that the proba-
bility of detecting a particle in the excitation volume is
less than one. If the excitation volume contains more than
one particle, and each particle is labeled with more than
one fluorophore, one can still extract the absolute number
of fluorophores per particle. This requires subtraction of
the correlation values at very long lag times, Minfinity, which
we obtain by calculating the correlations with fine spacing at
50 ms lag time using the algorithm described by Laurence
et al. (26). Taking this into account, the number of fluoro-
phores in a complex can be extracted by:
Mc Minfinity
Ml Minfinity
¼ 1 1
N
: (5)
This formula is a restatement of Eq. 3 of Tinnefeld et al. (19)
and Sy´kora et al. (21). Instead of fitting a functional form,
we integrate over the entire correlation peaks. We demon-
strate this by repeating the above experiments using
a high-concentration sample in which the probability of de-
tecting more than one particle per excitation volume is
greater than one. We determine this by analyzing the ampli-
tude of the autocorrelation G(0) ¼ 1/n from FCS measure-
ments. The antibunching peaks for the high-concentration
sample are shown in Fig. 3. For the singly and doubly
labeled samples, we determine values of N ¼ 1.26 5 0.15
and N ¼ 1.92 5 0.12, respectively, over eight separate
measurements of 10 min each. These values are summarized
in Table 2.
Our finding that there are two apo A-I molecules in rHDL
in solution is an important confirmation of previous results
obtained from protein cross-linking experiments (27).
However, cross-linking experiments require the introduction
of covalent interactions that can alter the inherent dynamic
properties of the protein. In addition, the use of cross-linkers
may lead one to select interactions based on local reactivity,
and therefore to trap interactions that may not be the most
prevalent under physiological conditions. Although our
results show that there are two apo A-I molecules per par-
ticle, this does not prove that the two monomers are boundTABLE 1 Low-concentration sample
Low-concentration sample Mc Ml Mc=Ml N
Singly labeled 34.17 210.13 0.15 1.195 0.10
Doubly labeled 71.90 135.30 0.52 2.105 0.19
Number of molecules N in a low-concentration sample is determined by
calculating the ratio Mc=Ml. The values given are arbitrary units averaged
over eight measurements.together to form a dimer, nor do they provide information
about the conformational state of apo A-I. However, they
do lend support to the double-belt model for nascent HDL.
Using these measurements, we were able to determine
that the sample was homogeneous, i.e., that most or nearly
all of the rHDL particles contained two apo A-I proteins.
From a technological point of view, the ability to directly
verify the stoichiometry and homogeneity of rHDL particles
in solution will enable quantitative assessment of rHDL,
which is increasingly being exploited for diverse biomedical
applications.Comparison with PCH
Here we compare photon antibunching spectroscopy with
the photon-counting histogram (PCH) method as an alterna-
tive way to count the number of apoA-I molecules on
the disc. Other, related methods, including fluorescence-
intensity distribution analysis (28) and photon arrival-time
interval distribution (29), may also be used for similar anal-
ysis; however, the PCH methodology was the simplest to
implement. PCH distinguishes different species based onTABLE 2 High-concentration sample
High-concentration
sample Mc Ml Minfinity
Mc Minfinity
Ml Minfinity N
Singly labeled 17.5 21.2 14.06 0.48 1.265 0.15
Doubly labeled 15.2 20.8 13.4 0.19 1.925 0.12
Number of molecules N is determined by using a modified ratio of Mc=Ml,
which accounts for the correlation at long lag times, Minfinity.
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temporal behavior as in the photon antibunching analysis.
The most important parameter in PCH is the molecular
brightness (photons/s/molecule). Because the time-tagged
time-resolved data format in the PicoHarp 300 stores the mi-
crotime and macrotime, we also used photons recorded for
antibunching histogram for the PCH analysis on the singly
labeled (control) and doubly labeled samples. In principle,
the doubly labeled sample should give twice the molecular
brightness compared with the singly labeled case if the
laser power is kept constant. We fit the photon probability
distribution to a model as described by Chen et al. (30)
using a 3D Gaussian point-spread function. The two
parameters in the fit were the number of molecules N and
the molecular brightness ε. Our data show a ratio of
ðdoubly labeled=singly labeledÞz1:8250:2 for the low
concentration and ðdoubly labeled=singly labeledÞz1:995
0:1 for the high concentration (Table 3). These values are
consistent with our prior photon antibunching analysis, and
provide additional evidence that the lipoprotein particles
contain two apoA-I molecules on the disc.
One might ask which methodology—PCH or photon anti-
bunching—is best for determining the number of emitters
on a biological molecule. The main advantage of the photon
antibunching methodology is that the singly labeled control
sample is not needed to quantitatively determine the number
of emitters. Correlations at time zero are used to determine
the absolute number of fluorophores on each biomolecule.
In contrast, for PCH, the singly labeled sample is required
as a reference for all other measurements. Furthermore,
comparing peaks at time zero and at long lag times also
allows for triplet-state effects to be quantified (21,26).
The cost of the experimental setup is frequently cited as
a drawback of photon antibunching. However, the optical
setup for photon antibunching is not significantly more
complicated to implement than PCH. For our particular
system, we use a picosecond pulsed laser (LDH 635-B;
PicoQuant GmbH) for excitation and a PicoHarp 300 to
record the photon arrival times. A significant portion of
the cost is incurred by the PicoHarp 300, but as relatively
inexpensive replacement one can use a counter-timer board
(such as the PCI-6602; National Instruments, Austin, TX) as
a histogrammer (26). Data stored in the counter-timer card
permit a dual analysis of antibunching and PCH in one
single measurement.
Another strength of the photon antibunching approach is
that data analysis is simpler. The peaks on the antibunchingTABLE 3 Molecular brightness ε determined by fitting the
PCH distribution
Sample
ε (photons/s/molecule)
low concentration
ε (photons/s/molecule)
high concentration
Singly labeled 74075 2291 80175 1329
Doubly labeled 13,5115 324 15,9795 771
Biophysical Journal 101(4) 970–975histogram can be fitted to the area under the curve (e.g., by
counting all photon pair events) and does not require
complicated fitting models involving idealized detection
volumes as in PCH, fluorescence-intensity distribution anal-
ysis, or photon arrival-time interval distribution. Because
photon antibunching is relatively novel in terms of particle
counting, determining the limit on the number of molecules
that can be counted has not been well investigated. It is
useful to determine singly, doubly, or triply labeled mole-
cules, which suits our rHDL studies well because these
particles are hypothesized to contain two apoA-I molecules
per disc. However, the zero peak becomes more difficult to
discern as the number of fluorophores, N, increases. When
N > 10, the amplitude of the zero peak is almost equivalent
to all lateral peaks. In this case, methods based on molecular
brightness will likely perform better.
Another potential issue in photon antibunching experi-
ments is that, at the peak at zero time difference, detecting
the photons requires two labels to be excited simultaneously.
If the labels are in close proximity, singlet-singlet annihila-
tion may skew the antibunching results (21,31).
Because photon antibunching measurements depend on
the second-order correlation function, the measurements
are sensitive to minor, brighter species. For example, in
our singly labeled sample, even though we estimated that
only 5% of the labeled species contained two labels, they
contributed ~20% of the correlation signal. If bright spikes
are present, it may be necessary to use techniques such as
purified FCS (32) or modulation filtering (33) to remove
signals from aggregates or bright species.CONCLUSION
By applying the quantum optical technique of photon anti-
bunching in this work, we were able to show that rHDL
contains two molecules of apo A-I in the hydrated state.
This method may be particularly valuable for elucidating
the dynamic and distribution properties of apoA-I on HDL
because it facilitates real-time observations of both stoichi-
ometry and particle size. Such information is difficult to
obtain directly by biochemical means. Our results provide
an important verification of the generally accepted model
for HDL structure in a more natural, solution environment.
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